Literature DB >> 25634624

Henipavirus pathogenesis and antiviral approaches.

Cyrille Mathieu1, Branka Horvat.   

Abstract

Hendra virus and Nipah virus are closely related, recently emerged zoonotic paramyxoviruses, belonging to the Henipavirus genus. Both viruses induce generalized vasculitis affecting particularly the respiratory tract and CNS. The exceptionally broad species tropism of Henipavirus, the high case fatality rate and person-to-person transmission associated with Nipah virus outbreaks emphasize the necessity of effective antiviral strategies for these intriguing threatening pathogens. Current therapeutic approaches, validated in animal models, target early steps in viral infection; they include the use of neutralizing virus-specific antibodies and blocking membrane fusion with peptides that bind the viral fusion protein. A better understanding of Henipavirus pathogenesis is critical for the further advancement of antiviral treatment, and we summarize here the recent progress in the field.

Entities:  

Keywords:  Hendra virus; Nipah virus; bats; emergent diseases; encephalitis

Mesh:

Substances:

Year:  2015        PMID: 25634624     DOI: 10.1586/14787210.2015.1001838

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  17 in total

1.  4'-Azidocytidine (R1479) inhibits henipaviruses and other paramyxoviruses with high potency.

Authors:  Anne L Hotard; Biao He; Stuart T Nichol; Christina F Spiropoulou; Michael K Lo
Journal:  Antiviral Res       Date:  2017-06-17       Impact factor: 5.970

2.  The Use of Large-Particle Aerosol Exposure to Nipah Virus to Mimic Human Neurological Disease Manifestations in the African Green Monkey.

Authors:  Ji Hyun Lee; Dima A Hammoud; Yu Cong; Louis M Huzella; Marcelo A Castro; Jeffrey Solomon; Joseph Laux; Matthew Lackemeyer; J Kyle Bohannon; Oscar Rojas; Russ Byrum; Ricky Adams; Danny Ragland; Marisa St Claire; Vincent Munster; Michael R Holbrook
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

3.  Dual microRNA Screens Reveal That the Immune-Responsive miR-181 Promotes Henipavirus Entry and Cell-Cell Fusion.

Authors:  Chwan Hong Foo; Christina L Rootes; Karla Cowley; Glenn A Marsh; Cathryn M Gould; Celine Deffrasnes; Christopher J Cowled; Reuben Klein; Sarah J Riddell; Deborah Middleton; Kaylene J Simpson; Lin-Fa Wang; Andrew G D Bean; Cameron R Stewart
Journal:  PLoS Pathog       Date:  2016-10-26       Impact factor: 6.823

4.  Loss in lung volume and changes in the immune response demonstrate disease progression in African green monkeys infected by small-particle aerosol and intratracheal exposure to Nipah virus.

Authors:  Yu Cong; Margaret R Lentz; Abigail Lara; Isis Alexander; Christopher Bartos; J Kyle Bohannon; Dima Hammoud; Louis Huzella; Peter B Jahrling; Krisztina Janosko; Catherine Jett; Erin Kollins; Matthew Lackemeyer; Daniel Mollura; Dan Ragland; Oscar Rojas; Jeffrey Solomon; Ziyue Xu; Vincent Munster; Michael R Holbrook
Journal:  PLoS Negl Trop Dis       Date:  2017-04-07

5.  Host gene expression profiles in ferrets infected with genetically distinct henipavirus strains.

Authors:  Alberto J Leon; Viktoriya Borisevich; Nahal Boroumand; Robert Seymour; Rebecca Nusbaum; Olivier Escaffre; Luoling Xu; David J Kelvin; Barry Rockx
Journal:  PLoS Negl Trop Dis       Date:  2018-03-14

6.  Fusion Inhibitory Lipopeptides Engineered for Prophylaxis of Nipah Virus in Primates.

Authors:  Cyrille Mathieu; Matteo Porotto; Tiago N Figueira; Branka Horvat; Anne Moscona
Journal:  J Infect Dis       Date:  2018-06-20       Impact factor: 5.226

7.  Human Paramyxovirus Infections Induce T Cells That Cross-React with Zoonotic Henipaviruses.

Authors:  Rory D de Vries; Alwin de Jong; R Joyce Verburgh; Lucie Sauerhering; Gijsbert P van Nierop; Robert S van Binnendijk; Albert D M E Osterhaus; Andrea Maisner; Marion P G Koopmans; Rik L de Swart
Journal:  mBio       Date:  2020-07-07       Impact factor: 7.867

8.  Aerosol exposure to intermediate size Nipah virus particles induces neurological disease in African green monkeys.

Authors:  Dima A Hammoud; Margaret R Lentz; Abigail Lara; Jordan K Bohannon; Irwin Feuerstein; Louis Huzella; Peter B Jahrling; Matthew Lackemeyer; Joseph Laux; Oscar Rojas; Philip Sayre; Jeffrey Solomon; Yu Cong; Vincent Munster; Michael R Holbrook
Journal:  PLoS Negl Trop Dis       Date:  2018-11-21

9.  Development of a novel real-time polymerase chain reaction assay for the quantitative detection of Nipah virus replicative viral RNA.

Authors:  Kenneth S Jensen; Ricky Adams; Richard S Bennett; John Bernbaum; Peter B Jahrling; Michael R Holbrook
Journal:  PLoS One       Date:  2018-06-19       Impact factor: 3.240

10.  Protection from Hendra virus infection with Canarypox recombinant vaccine.

Authors:  Vanessa Guillaume-Vasselin; Laurent Lemaitre; Kévin P Dhondt; Laurence Tedeschi; Amelie Poulard; Catherine Charreyre; Branka Horvat
Journal:  NPJ Vaccines       Date:  2016-07-28       Impact factor: 7.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.